
Research news
We dedicate our efforts to delivering products with the innovative technologies that allow you to push forward and break new ground. Here we highlight recent publications featuring the remarkable and interesting scientific discoveries being made by our customers.
Engineered PsCas9: a precise, efficient tool for therapeutic genome editing
Date: March 11, 2025
Categories: Research News
Enhancing efficiency and safety of CRISPR-Cas tools with the optimized version of PsCas9: engineered PsCas9.
DNA origami: revolutionizing cell nucleus delivery of functionalized DNA nanostructures
Date: February 11, 2025
Categories: Research News
An innovative approach to deliver DNA nanostructures into live cell nuclei.
Demystifying and simplifying the lentiviral production and transduction workflow
Date: January 28, 2025
Categories: Research News
Understanding and simplifying the lentiviral workflow to enhance the overall performance of lentiviral transduction experiments.
On-demand pharmaceuticals in space: Bacillus subtilis revolutionizes astropharmacy
Date: December 5, 2024
Categories: Research News
Bacillus subtilis can be engineered to produce life-saving medicines on-demand, in the vastness of space.
Optimize your NGS: work with a polymerase that works
Date: May 19, 2023
Categories: Research News
This study highlights the importance of carefully selecting enzymes when amplifying NGS libraries, with Takara Ex Premier polymerase giving unbiased, highly sensitive, and precise results.
Zooming in: a new hiPSC model for type 2 diabetes in a predisposed population
Date: January 24, 2023
Categories: Research News
Researchers generated pancreatic beta cell-like cells from patient-specific tissue to mimic type 2 diabetes in a predisposed population.
TCR-seq methods: strengths, weaknesses, and rankings
Date: October 27, 2020
Categories: Research News
A new study by Dr. Encarnita Mariotti-Ferrandiz and her team compares commercial and academic NGS techniques for TCR repertoires.
A faster path to analysis for monoclonal antibodies as therapeutic agents
Date: June 10, 2020
Categories: Research News
Researchers at Merck & Co., Inc. assess the use of rapid membrane processing for sample prep prior to PK studies in the drug development pipeline.
ICELL8 technology keeps cardiovascular research pumping
Date: May 5, 2020
Categories: Automation | NGS | Research News | Single-cell
The beat goes on with the ICELL8 system and cardiomyocyte isolation in two new research papers.
Unraveling the world of microorganisms
Date: January 29, 2020
Categories: NGS | Research News
Learn how the authors used host nucleic acid depletion to get meaningful metagenomic NGS results from human CSF surrogate samples.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2025 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.